The chikungunya virus virus-like particle vaccine is well tolerated and shows high immunogenicity in both previous recipients ...

Valneva will work with local health authorities and wholesalers on the French island territory to distribute the vaccines.

Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age and older.

“As the first virus-like particle single-dose, pre-filled syringe chikungunya vaccine, Vimkunya provides a crucial new tool to help protect at-risk individuals traveling to regions where the ...

The global animal vaccines market was valued at $9,093.9 million in 2020, and is projected to reach $13,780.6 million by 2028, registering a CAGR of 5.3% from 2021 to 2028. The market is expected to ...

The number of influenza cases is surging across the United States, putting significant strain on many hospitals. We asked the ...

Shares of GeoVax Labs, Inc. (NASDAQ:GOVX – Get Free Report) have received an average recommendation of “Buy” from the seven ...

COVID and the 1918 flu pandemic gave us playbooks on how to prepare for the next pandemic. But we aren’t using it.

Measles virus particle, illustration. (Photo by KATERYNA KON/SCIENCE PHOTO ... meaning it was without continuous spread for at least 12 months. MMR vaccine is like a shield The CDC currently ...